Amanote Research

Amanote Research

    RegisterSign In

Combo Drug Strategy Tested for PDAC

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2019-037
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

March 19, 2019

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)


Related search

Drug Combo May Be Effective in Ovarian Cancer

Cancer Discovery
Oncology
2014English

Combo Index

2020English

Targeted Combo Effective for Refractory Ewing Sarcoma

Cancer Discovery
Oncology
2012English

Combo Therapy for Lung Cancer Extends Survival

Cancer Discovery
Oncology
2018English

Combo That, Please!

Science
MultidisciplinaryPhilosophy of ScienceHistory
2011English

Validating the Vitality Strategy for Fighting Drug Resistance

Proteins: Structure, Function and Genetics
BiochemistryStructural BiologyMolecular Biology
2012English

Atezolizumab Combo Approved for PD-L1–positive TNBC

Cancer Discovery
Oncology
2019English

Epigenomic Changes Prime PDAC Metastasis

Cancer Discovery
Oncology
2017English

A New B-Raf Inhibitor Combo for Advanced Melanoma

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy